Pricing Log in Create free account

Elicio Therapeutics, Inc. (ELTX) vs eXoZymes Inc. (EXOZ)

Elicio Therapeutics, Inc. and eXoZymes Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and eXoZymes Inc. are of similar size ($38.1M and $37.9M). Across the 9 metrics below, eXoZymes Inc. leads on 6 and Elicio Therapeutics, Inc. on 3.

Valuation

Metric ELTX EXOZ Biotechnology median
P/E n/m n/m 10.60
P/S 1.01 n/m 9.40
P/B 3.69 10.43 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.56 n/m 9.02
Earnings yield (142.76%) (27.05%) (32.88%)
Free cash flow yield (129.21%) (18.74%) (23.13%)

Profitability

Metric ELTX EXOZ Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (774.56%) (187.16%) (51.96%)
Return on assets (124.36%) (115.42%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ELTX EXOZ Biotechnology median
Revenue growth (TTM) 921.02% — 6.76%
EPS growth (last fiscal year) 39.29% (22.47%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ELTX EXOZ Biotechnology median
Debt to equity 1.20 0.01 0.00
Current ratio 2.77 3.81 4.97
Net debt to EBITDA 0.25 0.31 1.01

Dividend

Metric ELTX EXOZ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ELTX EXOZ Biotechnology median
Market cap 37.93m 38.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack